Pharmacological development for MS is growing up in the last years. Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivation has shown high efficacy [17] . Safety and tolerability of fingolimod has been better understood [18, 19] . Therapeutic potential of curcumin is a matter of debate [20] . Tetrahydrocannabinolcannabidiol (THC/CBD) oromucosal spray has shown to be effective in improving overactive bladder symptoms in MS patients demonstrating a favorable impact on detrusor overactivity [21] , and treatment with botulinum toxin type A (BoNT-A) for MS-related spasticity has beneficial effects but also high level of discontinuation [22] . Myeloablative autologous hematopoietic stem cell transplant (AHSCT) has proven to be safe and efficacious to control the aggressive forms of MS with better outcome in RR-MS [23] .
Alzheimer's disease (AD) is the main cause of dementia, but rarer alternative diagnosis such as Creutzfeldt-Jakob disease and Whipple disease has to be considered [24, 25] . Also, dementia with Lewy body (LBD) is often misdiagnosed as AD [26, 27] . Association of arterial stiffness with cognition impairment in patients with Lewy body disorder has been evaluated and compared with AD findings [28] .
Benzodiazepines (BZD) and cognitive impairment represent an interesting aspect of research, since patients with highdose BZD intake show profound changes in cognitive function [29] . Several articles reported neuropsychological assessments to distinguish AD from normal aging and from other dementias (vascular dementia, frontotemporal dementia, LBD) [30] [31] [32] [33] [34] [35] . Recently, eye-tracking has been proposed as an integrative tool for cognitive assessment [36] . Cognitive training, active music therapy, and neuroeducation are emerging issues in mild-moderate AD [37, 38] .
Parkinson's disease (PD) is the most important field of research into movement disorders. Headache is a widespread disorder and therefore it has a strong impact on quality of life [62, 63] , also among children [64] [65] [66] [67] . Migraine pathophysiology is not clearly understood, but it is commonly accepted that female hormones play a negative role [68, 69] . Calcitonin gene-related peptide (CGRP) may play an important role in cluster headache pathophysiology and could represent a potential therapeutic target [70, 71] . Migraine chronicization is a daunting complication and is probably also linked to structural, functional, and metabolic changes in the brain, especially involving the brainstem [72] . Infusion of methylprednisolone and diazepam should determine a consistent reduction in headache frequency and drug assumption during the detoxification for medication overuse headache [73] . Triptans remain highly effective for the treatment of acute migraine attacks [74] , and intravenous mannitol for a high number of unresponsive migraine status [75] . Hypertension has been identified as one of the most important factors of chronic transformation of episodic migraine and increases the cerebrovascular and cardiovascular risk of migraine patients [76] . Telmisartan, a long-acting angiotensin II receptor blocker, has preventative benefits in non-responsive migraineurs [77] . OnabotulinumtoxinA, an effective treatment of chronic migraine, presents an increase of therapy efficacy and a progressive trend of "first-time response" [78] . Recent clinical experiences have demonstrated the safety, tolerability, and efficacy of non-invasive vagus nerve stimulation for the acute and prophylactic treatment of migraine also in adolescents [79] [80] [81] [82] . Greater occipital nerve block may represent a therapeutic alternative in chronic migraine [83] , while transcutaneous supraorbital neurostimulation is a promising technique [84] . Mindfulness or behavioral therapy is emerging as a helpful treatment for pain, also for chronic migraine [85, 86] , while the role of nutraceuticals in migraine prophylaxis is debated [87] . Ketogenic diet is a promising therapy to counteract neuroinflammation in migraine [88] . Cognitive performances in migraine patients show an impairment of executive functions, probably linked to the white matter lesions and the long history of drug abuse [89] [90] [91] .
Epilepsy remains a field of high interest for neurologists, hard to treat in a not low percentage of cases, especially for secondary epilepsy [92] [93] [94] . Ketogenic diet may be effective but nutritional risks and potential impacts on biochemical nutritional status are possible [95] . Vigabatrin is associated with ocular disorders and evaluation of inner retinal layers with optic coherence tomography can have role in future monitoring of patients [96] . The role of phenytoin toward peripheral nerves is debated [97] . An early involvement of striatum/ pallidus on MRI in super refractory status epilepticus has been recently associated with severe prognosis [98] .
Research of pathogenic mechanism of amyotrophic lateral sclerosis (ALS) remains a point of principal interest, above all for the potential therapeutic target [99] [100] [101] . The association of multiple metals is probably involved in ALS degeneration [102] . Cognitive assessment for ALS patients is easily investigated with the Edinburgh Cognitive and Behavioural ALS Screen [103] .
Atypical clinical Myasthenia Gravis (MG) patients may have been described [104] . Circulating follicullar helper T (cTfh) cells are significantly higher in MG and may play a role in the immunopathogenesis and the production of antiAChR Ab [105] . Tacrolimus is a valid option for the management of MG [106] . Coexistence of ALS and MG has been described and is associated with a bulbar onset and a worse prognosis [107] . Thymectomy represents an effective treatment for patients with non-thymomatous ocular myasthenia gravis [108] .
Familial amyloidotic polyneuropathy is now easily diagnosed with genetic test and salivary gland biopsy [109] [110] . High-dose intravenous immunoglobulin is a confirmed efficacious therapy for multifocal motor neuropathy [111] . Diagnosis of dysimmune peripheral neuropathies remains hard in some cases [112] [113] [114] [115] .
Primary brain tumors present a growing prevalence, especially among elderly people [116] . Expression of specific microRNA is related to pathological grading and prognosis of glioma [117, 118] and an evidence linking mobile phone use and risk of brain tumors has been found, especially in longterm users [119] . Extent of perilesional edema in brain metastasis from non-small cell lung cancer could be a predictive factor of response and brain progression after radiosurgery [120] .
Many reports are dedicated to rare neurologic diseases, genetic disorders describing new developments on the molecular diagnosis [121] [122] , the clinical heterogeneity of the clinical spectrum [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] , and the therapeutic opportunities [135] [136] [137] .
In conclusion, during this year, Neurological Sciences has been full of interesting papers in many fields of neurological research, confirming the good quality and actuality of the journal.
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